Vera Corp (VERA) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Vera Therapeutics, Inc. (VERA) tadqiqotchilar va R&D mutaxassislaridan iborat shtatni mahorat bilan saqlab qolmoqda hamda olimlarni aniq ishlanmalarga bog'lash orqali kadrlar almashinuvini minimallashtirmoqda. Ushbu biotexnologiya startapi yangi dori vositalarini yaratishda ishtirok etish orqali biologlarni jalb qiladi va sodiqlikni ta'minlash uchun RSU opsiyalaridan foydalanadi. Jori narxlar dinamikasi 0.18 ko'rsatkichlarini aks ettirmoqda, biznesning moliyaviy barqarorligi esa buyrak dori vositalarining tartibga soluvchi organlar tomonidan tasdiqlanishiga bog'liq.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvypeoku.ae-7b8ozy8&start=20220704&end=20261101&filename=GURU_Markets_-_VERA_-_Vera-Therapeutics-Inc._-_Long-Term-Debt-to-Capital "VERA: Vera Therapeutics Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 01.11.2026 | 👁️GURU.Markets👁️")
Vera Therapeutics, Inc. (VERA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Vera Therapeutics, Inc.|VERA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati veratx.com|VERA - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Vera Therapeutics, Inc.|VERA - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Vera Therapeutics|Tezkor likvidlik ko‘rsatkichi veratx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Vera Therapeutics Inc - VERA
Vera Therapeutics, Inc. (VERA) atacicept sinovlari natijalari bo'yicha noaniqlikka duch kelayotgan biotexnologiya sektori uchun operatsion yo'qotishlar fonida qarz yukini boshqarish omon qolish uchun juda muhimdir. Uzoq muddatli kreditlarning kapitalga nisbatini tahlil qilish majburiyatlar tuzilmasidagi uzoq muddatli leveraj ulushini baholash imkonini beradi va bu esa yuqori tebranishlar davrida kompaniyaning aksiyadorlar kapitali hisobiga majburiyatlarni qoplash qobiliyatini belgilaydi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|DNTH (Dianthus Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati PHVS (Pharvaris Corp)|Uzoq muddatli qarzdorlikning kapitalga nisbati AbCellera (ABCL)|TRML - Uzoq muddatli qarzning o'z kapitaliga nisbati|precigen.com (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Pharming Group (PHAR) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Nektar Therapeutics Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati UPB|Uzoq muddatli qarzning kapitalga nisbati Zenas Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunome, Inc. (IMNM)|gossamerbio.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|PVLA: Uzoq muddatli qarzning o'z kapitaliga nisbati|SVRA: Uzoq muddatli qarzning o'z kapitaliga nisbati|RIGL: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati anaptysbio.com (ANAB)|Uzoq muddatli qarzning o'z kapitaliga nisbati Astria Therapeutics, Inc.|ENGN: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati RAPT|Uzoq muddatli qarzning kapitalga nisbati aerovatetx.com (JBIO)|Aclaris Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KYTX|TLSA: Uzoq muddatli qarzning o'z kapitaliga nisbati|Cabaletta Bio Inc. - Uzoq muddatli kreditlarning kapitalga nisbati|VTYX: Uzoq muddatli qarzning kapitalga nisbati|Theratechnologies, Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|AVTX (Avalo Therapeutics, Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati eledon.com ELDN|Uzoq muddatli qarzning o'z kapitaliga nisbati Agenus Inc. (AGEN)|CLYM (Climb Bio Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ZURA (Zura Bio Limited)|Uzoq muddatli qarzning kapitalga nisbati aTyr Pharmaceuticals ATYR|ADAG - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati IMA|STTK: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Equillium (EQ)|Uzoq muddatli qarzning o'z kapitaliga nisbati CNTB|Uzoq muddatli qarzning kapitalga nisbati Immunic Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati ATRA (Atara Biotherapeutics)|Uzoq muddatli kreditlarning kapitalga nisbati IFRX|Uzoq muddatli qarzning kapitalga nisbati XFOR (X4 Pharmaceuticals, Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati Adicet Bio Inc. (ACET)|Celularity Corp - Uzoq muddatli qarzning kapitalga nisbati|INmune Bio Corporation (INMB) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Barinthus Biotherapeutics (BRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|KZR - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati SABS|AKTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ENLV|Uzoq muddatli qarzdorlikning kapitalga nisbati q32bio.com|Uzoq muddatli qarzning o'z kapitaliga nisbati GeoVax Labs, Inc. GOVX|EDSA: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|iBio - Uzoq muddatli qarzning kapitalga nisbati|Carisma Therapeutics (CARM) - Uzoq muddatli qarzning o'z kapitaliga nisbati|XTLB (XTL Biopharmaceuticals, Ltd.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|BOLT - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati HCWB|Uzoq muddatli qarzning o'z kapitaliga nisbati APVO|Uzoq muddatli qarzning kapitalga nisbati AIM|ADTX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati GRI Bio Corp GRI|Uzoq muddatli qarzning kapitalga koeffitsiyenti XRTX|Vyome Holdings Inc - Uzoq muddatli qarzning kapitalga nisbati|REVB - Uzoq muddatli qarzning kapitalga nisbati|Indaptus Therapeutics, Inc. (INDP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati SCNI (Scinai Immunotherapeutics Ltd)|CALI (CalciMedica Inc) - Uzoq muddatli qarzning kapitalga nisbati|AFMD: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ALLK|Uzoq muddatli qarzning kapitalga nisbati hookipapharma.com (HOOK)|Uzoq muddatli qarzning o'z kapitaliga nisbati IGM Biosciences IGMS|Uzoq muddatli qarzning kapitalga koeffitsiyenti ITOS|OCEA - Uzoq muddatli qarzning o'z kapitaliga nisbati|TC BioPharm Ltd (TCBP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|THRD: Uzoq muddatli qarzning kapitalga nisbati